Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease

被引:34
|
作者
Kostner, KM [1 ]
Fahti, RB [1 ]
Case, C [1 ]
Hobson, P [1 ]
Tate, J [1 ]
Marwick, TH [1 ]
机构
[1] Univ Queensland, Princess Alexandra Hosp, Dept Med, Brisbane, Qld 4102, Australia
关键词
inflammation; complement; endothelial function; coronary syndromes;
D O I
10.1016/j.cca.2005.08.028
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Endothelial dysfunction plays an important role in the pathogenesis of coronary artery disease (CAD). Apart from traditional risk factors complement activation and inflammation may trigger and sustain endothelial dysfunction. We sought to assess the association between endothelial function, high sensitivity C-reactive protein (hs-CRP) and markers of complement activation in patients with either stable or unstable coronary artery disease. Methods: We prospectively recruited 78 patients, 35 patients with stable angina pectoris (SAP) and 43 patients with unstable angina pectoris (UAP). Endothelial function was assessed as brachial artery reactivity (BAR). Hs-CRP, C3a, C5a, and C1-Inhibitor (C1 inh.) were measured enzymatically. Results: Patients with IJAP showed higher median levels of hs-CRP and C3a compared to patients with SAP, while BAR was not significantly different between patient groups. In UAP patients, hs-CRP was significantly correlated with cholesterol (r = 0.27, p < 0.02), C3a (r = 0.32, p < 0.001) and C1 INH.(r = 0.41, p < 0.003), but not with flow mediated dilatation (r = 0.09, P = 0.41). Hs-CRP and C1 INH.were found to be independant predictors of IJAP in a backward stepwise logistic regression model. Conclusions: We conclude that both hs-CRP, a marker of inflammation and C3a, a marker of complement activation are elevated in patients with UAP, but not in patients with SAP. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 50 条
  • [1] Effect of sulfasalazine on inflammation and endothelial function in patients with established coronary artery disease
    Tabit, Corey E.
    Holbrook, Monica
    Shenouda, Sherene M.
    Dohadwala, Mustali M.
    Widlansky, Michael E.
    Frame, Alissa A.
    Kim, Brian H.
    Duess, Mai-Ann
    Kluge, Matthew A.
    Levit, Aaron
    Keaney, John F., Jr.
    Vita, Joseph A.
    Hamburg, Naomi M.
    VASCULAR MEDICINE, 2012, 17 (02) : 101 - 107
  • [2] Clopidogrel Improves Microvascular Endothelial Function in Subjects with Stable Coronary Artery Disease
    Willoughby, Scott R.
    Luu, Lee-Jen
    Cameron, James D.
    Nelson, Adam J.
    Schultz, Carlee D.
    Worthley, Stephen G.
    Worthley, Matthew I.
    HEART LUNG AND CIRCULATION, 2014, 23 (06) : 534 - 541
  • [3] Ranolazine improves endothelial function in patients with stable coronary artery disease
    Deshmukh, Smriti H.
    Patel, Snehal R.
    Pinassi, Elsa
    Mindrescu, Catalin
    Hermance, Eileen V.
    Infantino, Michael N.
    Coppola, John T.
    Staniloae, Cezar S.
    CORONARY ARTERY DISEASE, 2009, 20 (05) : 343 - 347
  • [4] Clopidogrel Improves Microvascular Endothelial Function in Patients with Stable Coronary Artery Disease
    Willoughby, Scott R.
    Luu, Lee Jen
    Nelson, Adam J.
    Cameron, James D.
    Worthley, Stephen
    Worthley, Matthew I.
    CIRCULATION, 2012, 126 (21)
  • [5] Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease
    Kirma, Cevat
    Akcakoyun, Mustafa
    Esen, Ali Metin
    Barutcu, Irfan
    Karakaya, Osman
    Saglam, Mustafa
    Kargin, Ramazan
    Turkmen, Muhsin
    Boztosun, Bilal
    Izgi, Akin
    Sonmez, Kenan
    CIRCULATION JOURNAL, 2007, 71 (05) : 698 - 702
  • [6] The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease
    Sokol, Seth I.
    Srinivas, Vankeepuram
    Crandall, Jill P.
    Kim, Mimi
    Tellides, George
    Lebastchi, Amir
    Yu, Yiting
    Gupta, Alok K.
    Alderman, Michael H.
    VASCULAR MEDICINE, 2012, 17 (06) : 394 - 404
  • [7] Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease
    Oldgren, J
    Wallentin, L
    Grip, L
    Linder, R
    Norgaard, BL
    Siegbahn, A
    EUROPEAN HEART JOURNAL, 2003, 24 (01) : 86 - 93
  • [8] Endothelial function of the popliteal artery in patients with coronary artery disease
    Angerer, P
    Negut, C
    Störk, S
    von Schacky, C
    ATHEROSCLEROSIS, 2001, 155 (01) : 187 - 193
  • [9] Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease
    Rein, Philipp
    Saely, Christoph H.
    Silbernagel, Guenther
    Vonbank, Alexander
    Mathies, Rainer
    Drexel, Heinz
    Baumgartner, Iris
    ATHEROSCLEROSIS, 2015, 239 (02) : 299 - 303
  • [10] Absence of differential effect of ticagrelor versus prasugrel maintenance dose on endothelial function in patients with stable coronary artery disease
    Xanthopoulou, Ioanna
    Bei, Ilianna
    Bampouri, Theodora
    Barampoutis, Nikolaos
    Moulias, Athanasios
    Davlouros, Periklis
    Alexopoulos, Dimitrios
    HELLENIC JOURNAL OF CARDIOLOGY, 2019, 59 (06) : 338 - 343